http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017009236-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
filingDate 2016-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdce5a88f2fd23d990498ff8f6b7b7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2ce9a623b4dc379e6425f2ed9d4431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e24ffce11e73f02dba921bb1c6fb723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa357a46141660028c775b61cbd5565d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4744d44f2028826732a9ccc516c68956
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f91635eec447d660044ed59db1053d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4305c0b17ebb16bbc2b31c45770aac8e
publicationDate 2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017009236-A3
titleOfInvention New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists
abstract The present invention relates to dual GLP-1 / glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.
priorityDate 2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011000095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013093720-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011024110-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015100876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015086731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014081872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013336893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007139941-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16157882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314

Total number of triples: 39.